… Compared to subjects with stable coronary artery disease (CAD), patients with ACS show
higher levels of sLOX-1 (0.579 ng/mL versus 1.61 ng/mL, P < 0.01) [14]; patients with ACS …

… be activated by other risk factors of coronary artery disease (CAD), including hemodynamic
… domain, LOX-1 can convert into soluble molecules by proteolytic cleavage at its membrane …

… The rate of smoking, history of coronary artery disease, hypertension, and diabetes mellitus
were similar in both groups (Table 1). In the biochemical examination; fasting glucose, serum …

… soluble LOX-1 is associated with proximal/mid and distal segment of the left anterior descending
(LAD) artery lesion … Furthermore, this study suggested soluble LOX-1 might be a useful …

BACKGROUND:: Although serum soluble lectin-like oxidized low-density lipoprotein
receptor-1 (sLOX-1) is reported to be associated with acute coronary syndrome (ACS), its …

… possible role of circulating cLDL and soluble LOX-1 (sLOX-1) as potential biomarkers of
metabolic syndrome (MetS) as well as of coronary artery disease (CAD) among MetS patients. …

… Biomarkers are a useful tool for the diagnosis and reflect the pathogenesis of coronary
artery disease (CAD) [1]. Creatine kinase- (CK-) MB and troponins are derived from damaged …

… disease. MBL appears to be involved in the pathogenesis of atherosclerosis and, in
consequence, coronary artery disease … Moreover, the soluble terminal complex, resulting from all …

… Generation of sLOX‐1 (soluble lectin‐like oxidized low‐density lipoprotein receptor 1) from
… Elevated sLOX ‐1 concentrations are shown in stable coronary artery disease ( CAD ), acute …

… coronary artery disease. This fits … artery disease and lower limb arterial disease, which are
not accounted for in our imaging measures. There is a significant correlation between disease …